NovoCure Limited (NASDAQ:NVCR) Q3 2025 Earnings Call Transcript October 30, 2025
NovoCure Limited beats earnings expectations. Reported EPS is $-0.33304, expectations were $-0.42.
Operator: Good day, and thank you for standing by. Welcome to the Novocure Third Quarter 2025 Earnings Call. [Operator Instructions] Please be advised, today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Ingrid Goldberg. Please go ahead.
Ingrid Goldberg: Good...
